TERF2 Primary Antibody

Item Information
Catalog #
Size
Price
Description
This gene encodes a telomere specific protein, TERF2, which is a component of the telomere nucleoprotein complex. This protein is present at telomeres in metaphase of the cell cycle, is a second negative regulator of telomere length and plays a key role in the protective activity of telomeres. While having similar telomere binding activity and domain organization, TERF2 differs from TERF1 in that its N terminus is basic rather than acidic.


Product Overview
Formulation
Purified antibody in PBS with 0.05% sodium azide.
Storage
4°C; -20°C for long term storage
Product Image
Western Blot
Figure 1: Western blot analysis using TERF2 mAb against human TERF2 (AA: 324-500) recombinant protein. (Expected MW is 39.7 kDa)
Figure 1: Western blot analysis using TERF2 mAb against human TERF2 (AA: 324-500) recombinant protein. (Expected MW is 39.7 kDa)
Western Blot
Figure 2: Western blot analysis using TERF2 mAb against HEK293 (1) and TERF2 (AA: 324-500)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 2: Western blot analysis using TERF2 mAb against HEK293 (1) and TERF2 (AA: 324-500)-hIgGFc transfected HEK293 (2) cell lysate.
Immunohistochemical analysis
Figure 3: Immunohistochemical analysis of paraffin-embedded ovarian cancer tissues using TERF2 mouse mAb with DAB staining.
Figure 3: Immunohistochemical analysis of paraffin-embedded ovarian cancer tissues using TERF2 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 4: Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using TERF2 mouse mAb with DAB staining.
Figure 4: Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using TERF2 mouse mAb with DAB staining.
Elisa
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
For Research Use Only. Not for use in diagnostic procedures.